Inventor
Christel Larbouret
Inventor
Montpellier, FR
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07KPeptides31%
A61KPreparations for medical, dental or toiletry purposes27%
G01NInvestigating or analysing materials by determining their chemical or physical properties12%
PatentTitleYear
11,001,634Anti-human-HER3 antibodies and uses thereof202110,398,774Human monoclonal antibodies against AXL201910,196,455Neuregulin allosteric anti-HER3 antibody20199,522,956'Combination therapy using anti-EGFR and anti-HER2 antibodies'20169,409,988'Anti-Axl antibodies and uses thereof'20169,346,883'Antibodies against HER3'20169,249,228'Anti-Axl antibodies and uses thereof'20169,127,065'Anti-human HER3 antibodies and uses thereof'2015Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015–2021Patents assigned to INST NAT SANTE RECH MED (6)· patent assignee history
2015–2016Patents assigned to CHARDES THIERRY (4)· patent assignee history
2015–2016Patents assigned to LARBOURET CHRISTEL (4)· patent assignee history
2015–2016Patents assigned to PELEGRIN ANDRE (4)· patent assignee history
2015–2019Based in Montpellier, FR· patent location history
2016–2021Based in Valflaunes, FR· patent location history
2019–2021Patents assigned to INST REGIONAL CANCER MONTPELLIER (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INST NAT SANTE RECH MED | 6 | 2015–2021 |
| CHARDES THIERRY | 4 | 2015–2016 |
| LARBOURET CHRISTELself | 4 | 2015–2016 |
| PELEGRIN ANDRE | 4 | 2015–2016 |
| INST REGIONAL CANCER MONTPELLIER | 3 | 2019–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Montpellier, FR | 6 | 2015–2019 |
| Valflaunes, FR | 2 | 2016–2021 |